

Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing. Patient Square Capital led the round.
Source: Press Release
Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing.
Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing. Patient Square Capital led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination